Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 1998

View Archived Issues

Combination therapy incorporating antioxidants effective for treatment of H. pylori infection

Metrifonate appears to be beneficial for the treatment of mild to moderate AD

Transkaryotic Therapies: Q1 1998 highlights

E-4010: a potential new treatment for pulmonary hypertension

Scotia updates R&D portfolio

Anxiolytic and antidepressant effects of L-701324, a glycine receptor antagonist

Roche now copromoting Coreg with SKB

More European approvals obtained for balsalazide

Benzodiazepine agonists and their use described by Synthelabo

Pfizer discloses new CRF (CRH) antagonists

Novel glutamate receptor antagonists in development at Warner-Lambert

Exemestane now under regulatory review, P&U reports

CNRS investigators discover CFTR channel activators

Hydroxamic and carboxylic acid derivatives as inhibitors of MMPs and TNF production

Ro-19-4603 attenuates ethanol responding in alcohol-preferring rats

AltaRex outlines corporate strategy for next 12 to 18 months

Osiris awarded patent for the use of MSCs in bone marrow regeneration

New GABA-B antagonist shows memory-enhancing effects in rats

5-HT antibodies for treatment of alcoholism

Terrapin changes name to Telik to reflect company's progress

Peptide Therapeutics and Pasteur Merieux-OraVax to develop H. pylori vaccine

CP-336156: nonsteroidal estrogen agonist/antagonist with a better profile than estrogen

Myriad Genetics enters into agreement with Rockefeller University for cancer gene research

Isis and Ciba Vision file MAA for fomivirsen

Manganic porphyrins for treatment of hyperoxic lung injury

Corixa obtains option to license mammaglobin for the diagnosis of breast cancer

Profile of BIIC-1996, a novel dual NK1/NK2 antagonist for respiratory indications

Serono introduces Geref for treatment/diagnosis of GHD

P&U reports antiasthma agent with a novel mechanism of action

Levalbuterol shows improved therapeutic ratio over racemic albuterol

Proteus seeks partners, licensees for novel hypertension vaccine

Phase III trials with SB-207499 begin

Rebif reduces disease activity in patients with MS

Immunex completes BLA submission for Enbrel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...